GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Tianjin TEDA Biomedical Engineering Co Ltd (HKSE:08189) » Definitions » Net Change in Cash

Tianjin TEDA Biomedical Engineering Co (HKSE:08189) Net Change in Cash : HK$0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Tianjin TEDA Biomedical Engineering Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Tianjin TEDA Biomedical Engineering Co's Net Change in Cash for the three months ended in Dec. 2024 was HK$0.0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.0 Mil.

Tianjin TEDA Biomedical Engineering Co Net Change in Cash Historical Data

The historical data trend for Tianjin TEDA Biomedical Engineering Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin TEDA Biomedical Engineering Co Net Change in Cash Chart

Tianjin TEDA Biomedical Engineering Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.70 15.81 -21.87 -0.98 20.75

Tianjin TEDA Biomedical Engineering Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tianjin TEDA Biomedical Engineering Co Net Change in Cash Calculation

Tianjin TEDA Biomedical Engineering Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-28.049+-39.763+88.564+0
=20.8

Tianjin TEDA Biomedical Engineering Co's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=0+0+0+0
=0.0

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin TEDA Biomedical Engineering Co Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Tianjin TEDA Biomedical Engineering Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin TEDA Biomedical Engineering Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Tianjin TEDA Biomedical Engineering Co Ltd (HKSE:08189) » Definitions » Net Change in Cash
Comparable Companies
HKSE:00509 CTVA TSX:NTR DSMD:IQCD SAU:2020 CF SZSE:000792 MOS XTAE:ICL OSL:YAR BOM:506395 NSE:PIIND NSE:UPL SHSE:600096 BOM:590024 ADX:FERTIGLB FMC AMM:JOPH SZSE:000893 AMM:APOT
Traded in Other Exchanges
N/A
Address
No. 80, The 4th Avenue, 9th Floor, Block A2, Tianda Hi-Tech Park, TEDA Tianjin, Tianjin, CHN
Website
http://www.bioteda.com
Tianjin TEDA Biomedical Engineering Co Ltd is engaged in the research, development, and commercialization of biological compound fertilizers, providing elderly and health care services. It operates in two segments namely; biological compound fertilizers products, and elderly care and health care services. The company generates a majority of its revenue from the Fertilisers products segment which is engaged in manufacturing and selling biological compound fertiliser products, including active fertiliser, mixture with nitrogen, phosphorus, and potassium with various formulas, providing warehousing services, and processing and licensing of the fertiliser products. The People's Republic of China is the primary geographical market for the company.
Executives
Long Ortiz 2101 Beneficial owner

Tianjin TEDA Biomedical Engineering Co Headlines

No Headlines